Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
暂无分享，去创建一个
F. Bootz | D. Dietrich | P. Brossart | F. Bauernfeind | F. Kramer | S. Strieth | L. de Vos | A. Franzen | J. Gabrielpillai | R. Zarbl | Timo J. Vogt | G. Kristiansen | Simone Weider | Moritz Färber | Alina Hunecke | Ann-Kathrin Glosch